A citation-based method for searching scientific literature


List of co-cited articles
193 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
204
56



Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
197
29

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
32
28

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
39
24


Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.
Tomo Osako, Takuji Iwase, Masaru Ushijima, Rie Horii, Yasuyoshi Fukami, Kiyomi Kimura, Masaaki Matsuura, Futoshi Akiyama. Cancer Sci 2014
24
33

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
92
21

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
23
34

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
34
23

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Takafumi Kondo, Naoki Hayashi, Sachiko Ohde, Koyu Suzuki, Atsushi Yoshida, Hiroshi Yagata, Naoki Niikura, Takayuki Iwamoto, Kumiko Kida, Michiko Murai,[...]. J Surg Oncol 2015
20
40

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
179
21

Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
31
22

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
452
18

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
52
18

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
300
18

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
39
18

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
22
31


Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
30
20

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
P Meijnen, H S A Oldenburg, C E Loo, O E Nieweg, J L Peterse, E J T Rutgers. Br J Surg 2007
61
16

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
170
16

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
28
17

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
191
13

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
422
13

A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
Hyung Seok Park, Ha Yan Kim, Seho Park, Eun-Kyung Kim, Seung Il Kim, Byeong-Woo Park. Breast 2013
24
20



A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
129
13

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Caren Wilkie, Laura White, Elisabeth Dupont, Alan Cantor, Charles E Cox. Am J Surg 2005
91
13

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Elizabeth A Mittendorf, Cletus A Arciero, Veronica Gutchell, Jeff Hooke, Craig D Shriver. Curr Surg 2005
64
13

Ductal carcinoma in situ and sentinel lymph node biopsy.
Bok Kyoung Son, Jin Gu Bong, Sung Hwan Park, Young Ju Jeong. J Breast Cancer 2011
17
29

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
29
17

Gene expression profiling of the tumor microenvironment during breast cancer progression.
Xiao-Jun Ma, Sonika Dahiya, Elizabeth Richardson, Mark Erlander, Dennis C Sgroi. Breast Cancer Res 2009
431
13

Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management.
Yuya Sato, Takayuki Kinoshita, Junko Suzuki, Kenjiro Jimbo, Sota Asaga, Takashi Hojo, Masayuki Yoshida, Hitoshi Tsuda. Breast Cancer 2016
9
55

Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Susan Prendeville, Ciara Ryan, Linda Feeley, Fionnuala O'Connell, Tara Jane Browne, Martin J O'Sullivan, Michael W Bennett. Breast 2015
24
20

A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy.
Oldřich Coufal, Iveta Selingerová, Pavlína Vrtělová, Petr Krsička, Lucie Gabrielová, Pavel Fabian, Kateřina Stískalová, Monika Schneiderová, Alexandr Poprach, Ivan Justan. Biomed Res Int 2014
7
71

Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ.
Ahmed Yahia Al-Ameer, Sahar Al Nefaie, Badria Al Johani, Ihab Anwar, Taher Al Tweigeri, Asma Tulbah, Mohmmed Alshabanah, Osama Al Malik. World J Clin Oncol 2016
8
62

Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Lisa A Rutstein, Ronald R Johnson, William R Poller, David Dabbs, Jan Groblewski, Tina Rakitt, Allan Tsung, Thomas Kirchner, Jules Sumkin, Donald Keenan,[...]. Breast J 2007
44
10


Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
E Guillot, C Vaysse, J Goetgeluck, M C Falcou, B Couturaud, A Fitoussi, V Fourchotte, F Laki, C Malhaire, B Sigal-Zafrani,[...]. Breast 2014
11
36

Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Rita Sakr, Martine Antoine, Emmanuel Barranger, Gil Dubernard, Christine Salem, Emile Daraï, Serge Uzan. Breast J 2008
22
18


Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
166
10

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
247
10

Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
Min Yi, Savitri Krishnamurthy, Henry M Kuerer, Funda Meric-Bernstam, Isabelle Bedrosian, Merrick I Ross, Frederick C Ames, Anthony Lucci, Rosa F Hwang, Kelly K Hunt. Am J Surg 2008
47
10

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
10

Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis.
Tomo Osako, Takuji Iwase, Kiyomi Kimura, Rie Horii, Futoshi Akiyama. Cancer Sci 2013
12
33

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Jensen C C Tan, David R McCready, Alexandra M Easson, Wey L Leong. Ann Surg Oncol 2007
44
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.